Senographe Pristina™

Mammography system

Delivers superior diagnostic accuracy at the same low dose as a 2D FFDM, the lowest patient dose of all FDA approved DBT systems1.

AT A GLANCE

Optimized gantry design

97% were less anxious or not anxious at all thanks to gantry design2.

Greater comfort during exam

Less anxiety and more comfortable exam experience with patient-assisted compression device, Pristina Dueta2.

Lowest patient dose

Pristina mammography has the lowest patient dose of all FDA approved DBT system3.

Fast quality control

Weekly quality control can be performed within 15 minutes4.

Senographe Pristina™ provides a better mammography experience2

Designed for women by women

The Pristina mammography system is expertly designed to enhance your everyday capabilities and make patients feel more comfortable. Pristina is engineered for a better patient experience along the entire breast care pathway, from screening and diagnosis to treatment planning and monitoring.
Clarity for Radiologists

Low dose for diagnostic accuracy

Senographe Pristina is the only FDA approved 3D mammography that delivers at the same low dose as 2D FFDM the lowest patient dose of all FDA approved systems2. The platform is upgradeable to advanced applications, including contrast-enhanced mammography and biopsy.
CLINICAL SUPERIORITY

Exceptional image quality for diagnostic accuracy

Our engineering teams work passionately to develop solutions designed to achieve exceptional Image quality:
• 2D with eConstrast HD: the new processing improves the reading workflow by reducing the need to manually window our images and the radiologist confidence in our 2D image quality.
• 3D with ASIR Version 3: the new tomosynthesis reconstruction on the Senographe Pristina allows better visibility of microcalcifications with the MoCo (Motion correction) algorithm to correct possible patient movement. The fine structures look sharper, and the overall image rendering has optimized contrast settings. This method optimizes image quality, achieving significant X-ray dose reduction.
• CEM with Nira: thanks to the new recombination algorithm, the impact of the artifacts is significantly reduced for all readers and may improve confidence in the diagnosis5.
IMPROVED ERGONOMICS

Reduce risks for technologists

With dedicated functions for easier patient positioning, Senographe Pristina is engineered to reduce physical strain to help prevent work-related injuries. Increased patient comfort during the exam can also make positioning easier.
INCREASED PATIENT COMFORT

Pristina Dueta puts patients in control

Under the radiographer’s supervision and guidance, our technology allows patients to control compression for a more comfortable screening process.
RELATED CONTENT

Latest insights

 

Patient testimonial

The patient perspective on Senographe Pristina from CSE Center, Paris, France.

 

Listen to your peers

Patient comfort.

 

Education content

Test your ability to correctly detect lesions in mammography with DetectEDX.

 

Ready for change

Breast imaging expert and author Bonnie Rush shares the importance of transforming the patient experience.

RELATED PRODUCTS

Discover our breast care solutions

GE HealthCare continues to innovate and improve the mammography experience through Senographe Pristina and supporting products for imaging review, biopsy, and contrast-enhanced mammography.

Get in touch

Have a question? We would like to hear from you.

References
1. Superior diagnostic accuracy demonstrated in a reader study comparing the ROC AUC of GE screening protocol (V-Preview + 3D CC/MLO with 3D in STD mode) to that of 2D FFDM alone. V-Preview is the 2D synthesized image generated by GE Seno Iris mammography software from GE DBT images. FDA PMA P130020. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P130020.

2. IPSOS Patient Satisfaction Study sponsored by GE HealthCare, conducted with 315 patients across 2 sites in Europe, out of which 160 were offered the patient-assisted compression option, February 2017.

3. Comparison of patient dose delivered by FDA approved DBT devices as of February 2018 for a breast of average density, based on data presented in [1-2] and data on file. Device comparison includes GE SenoClaire, GE Senographe Pristina 3D in STD mode, Hologic Selenia Dimensions, Siemens Mammomat Inspiration, Fuji Aspire Cristalle [1. Bouwman, R. W. and al., et. 2015, Physics in Medicine & Biology, pp. 7893-7907; 2. NHSBSP Equipment Reports 1306, 1404, 1307, and on Fujifilm AMULET Innovality.]

4. Per system. For Pristina 2D & 3D. Data on file. GE HealthCare 2020.

5. 510(k) K211215. Patient motion 74%, skin fold 88%, halo 76% artifacts were reduced according to the 3 readers. Reader study performed by 3 MQSA qualified radiologists on 50 clinical images, comparing SenoBright HD with NIRA to current version.

JB07229XE